John Doyle

John Doyle, Dr.P.H., is an accomplished public health professional with extensive experience in academia and the biopharmaceutical industry. Currently serving as Chief Scientific Officer and President of Fortrea, John leads a consulting organization focusing on drug development and market access across multiple countries. Previously, John held significant roles at Exponent, Pfizer, and IQVIA, where contributions included leading health sciences groups, overseeing global healthcare innovation, and enhancing real-world evidence applications. John's academic tenure as an Adjunct Professor at Columbia University's Mailman School of Public Health complements a robust educational background, holding a Doctor of Public Health and a Master of Public Health in Epidemiology from Columbia, as well as a Bachelor of Science in Business Management and Applied Economics from Cornell University.